Clinical evidence of the role of Methanobrevibacter smithii in severe acute malnutrition.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
08 03 2021
08 03 2021
Historique:
received:
13
06
2020
accepted:
01
02
2021
entrez:
9
3
2021
pubmed:
10
3
2021
medline:
15
12
2021
Statut:
epublish
Résumé
Gut microbial dysbiosis has been shown to be an instrumental factor in severe acute malnutrition (SAM) and particularly, the absence of Methanobrevibacter smithii, a key player in energy harvest. Nevertheless, it remains unknown whether this absence reflects an immaturity or a loss of the microbiota. In order to assess that, we performed a case-control study in Mali using a propensity score weighting approach. The presence of M. smithii was tested using quantitative PCR on faeces collected from SAM children at inclusion and at discharge when possible or at day 15 for controls. M. smithii was highly significantly associated with the absence of SAM, detected in 40.9% controls but only in 4.2% cases (p < 0.0001). The predictive positive value for detection of M. smithii gradually increased with age in controls while decreasing in cases. Among children providing two samples with a negative first sample, no SAM children became positive, while this proportion was 2/4 in controls (p = 0.0015). This data suggests that gut dysbiosis in SAM is not an immaturity but rather features a loss of M. smithii. The addition of M. smithii as a probiotic may thus represent an important addition to therapeutic approaches to restore gut symbiosis.
Identifiants
pubmed: 33686095
doi: 10.1038/s41598-021-84641-8
pii: 10.1038/s41598-021-84641-8
pmc: PMC7940396
doi:
Types de publication
Clinical Trial
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
5426Références
Obesity (Silver Spring). 2015 Dec;23(12):2508-16
pubmed: 26524691
Int J Epidemiol. 2002 Dec;31(6):1246-52
pubmed: 12540730
Science. 2016 Feb 19;351(6275):
pubmed: 26912898
mBio. 2017 Nov 14;8(6):
pubmed: 29138298
Nature. 2014 Jun 19;510(7505):417-21
pubmed: 24896187
Appl Microbiol Biotechnol. 2018 Apr;102(7):3095-3104
pubmed: 29497795
Int J Obes (Lond). 2012 Jun;36(6):817-25
pubmed: 21829158
Sci Transl Med. 2017 May 17;9(390):
pubmed: 28515336
FEMS Microbiol Rev. 2015 Sep;39(5):631-48
pubmed: 25907112
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4599-606
pubmed: 21317366
N Engl J Med. 2013 Jan 31;368(5):425-35
pubmed: 23363496
Int J Obes (Lond). 2013 Nov;37(11):1460-6
pubmed: 23459324
Front Microbiol. 2019 Nov 01;10:2449
pubmed: 31736896
Science. 2013 Sep 6;341(6150):1241214
pubmed: 24009397
Proc Natl Acad Sci U S A. 2006 Jun 27;103(26):10011-6
pubmed: 16782812
Front Microbiol. 2017 Mar 10;8:355
pubmed: 28344572
Lancet. 2013 Aug 3;382(9890):427-451
pubmed: 23746772
BMJ. 2007 Oct 20;335(7624):806-8
pubmed: 17947786
SCN News. 1995;(12):10-4
pubmed: 12346313
Antonie Van Leeuwenhoek. 1994;66(1-3):271-94
pubmed: 7747937
Clin Microbiol Infect. 2016 Mar;22(3):258.e1-8
pubmed: 26551842
Front Microbiol. 2019 Dec 05;10:2796
pubmed: 31866971
PLoS One. 2009 Sep 17;4(9):e7063
pubmed: 19759898
Cochrane Database Syst Rev. 2019 May 15;5:CD009000
pubmed: 31090070
Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16767-72
pubmed: 18931303
Front Microbiol. 2017 May 23;8:899
pubmed: 28588566
Science. 2019 Jul 12;365(6449):
pubmed: 31296738
Sci Rep. 2019 Dec 9;9(1):18653
pubmed: 31819085
Aliment Pharmacol Ther. 2008 Jan 15;27(2):104-19
pubmed: 17973645
Am J Clin Nutr. 2016 Nov;104(5):1441-1449
pubmed: 27655441
Proc Natl Acad Sci U S A. 2007 Jun 19;104(25):10643-8
pubmed: 17563350
Science. 2019 Jul 12;365(6449):
pubmed: 31296739
FEMS Microbiol Lett. 2006 Jan;254(1):116-22
pubmed: 16451188
J Nutr. 2003 Nov;133(11 Suppl 2):4010S-4020S
pubmed: 14672304
Science. 2005 Jun 10;308(5728):1635-8
pubmed: 15831718
Sci Rep. 2016 May 17;6:26051
pubmed: 27183876